Introduction
============

Mitochondria undergo continuous fusion and fission to maintain their morphology and function ([@bib47]; [@bib41]; [@bib4]; [@bib22]; [@bib44]). Mitochondrial dynamics are implicated in various cellular processes such as apoptosis, cell differentiation, cell division, and development ([@bib28]; [@bib12]; [@bib31]). It acts as an important quality control mechanism, where fusion contributes to mitochondrial maintenance and fission allows for the segregation of dysfunctional mitochondria ([@bib43]; [@bib49]).

Fusion and fission events occur in a regulated, cyclic manner, determining the shape, size, and distribution of mitochondria ([@bib43]; [@bib23]; [@bib3]). Conserved GTPases of the dynamin family mediate mitochondrial fission and fusion: mitofusins (MFN1 and MFN2) and optic atrophy 1 (OPA1) are required for the fusion of mitochondrial outer (OM) and inner membranes (IM), respectively; dynamin-related protein 1 (DRP1) mediates mitochondrial fission. Fission sites are marked by the ER, which closely associates with the OM, generating defined membrane domains to which DRP1 are recruited ([@bib14]; [@bib27]).

Disturbances in the dynamic behavior of mitochondria cause various neurodegenerative diseases ([@bib20]; [@bib19]). Mutations in *OPA1* cause dominant optic atrophy ([@bib1]; [@bib7]). The loss of OPA1 impairs mitochondrial fusion, perturbs cristae structure, and increases the susceptibility of cells toward apoptosis ([@bib29]; [@bib5], [@bib6]; [@bib21]; [@bib24]). Overexpression of OPA1, however, protects against various apoptotic stimuli ([@bib6]). The biogenesis of OPA1 is regulated both at the transcriptional and posttranscriptional level ([@bib26]). The alternative splicing of *Opa1* pre-mRNA at exons 4, 4b, and 5b yields a total of eight isoforms expressed in a tissue-dependent manner ([@bib8]). These isoforms can modulate different functions of OPA1, as indicated by isoform-specific silencing of OPA1 variants ([@bib30]). The presence of proteolytic cleavage sites S1 and S2, encoded by exons 5 and 5b, respectively, introduces additional complexity ([@bib18]). Proteolysis at these sites results in the loss of the transmembrane domain of OPA1 and leads to the formation of short OPA1 forms (S-OPA1). At steady state, mature OPA1 undergoes constitutive processing at S1 and S2, leading to the accumulation of noncleaved, long OPA1 (L-OPA1) and short OPA1 (S-OPA1) forms. Mitochondrial fusion is thought to depend on the presence of L- and S-OPA1 ([@bib39]), which assemble into oligomeric complexes maintaining cristae structure ([@bib13]; [@bib48]). Various stress conditions including apoptotic stimulation disrupt these complexes and trigger the complete conversion of L-OPA1 into S-OPA1, inhibiting mitochondrial fusion ([@bib10]; [@bib18]; [@bib2]; [@bib39]; [@bib16]). Ongoing fission events fragment the mitochondrial network, allowing the selective removal of damaged mitochondria by mitophagy or the progression of apoptosis ([@bib49]). Proteolysis of OPA1 is therefore crucial for mitochondrial integrity and quality control.

Recent evidence revealed that the IM peptidase OMA1 and the *i*-AAA protease YME1L cleave OPA1 at S1 and S2, respectively. Loss of OMA1 impairs OPA1 processing at S1 but does not grossly affect mitochondrial morphology ([@bib11]; [@bib17]). However, OMA1 is required for the stress-induced cleavage of OPA1 and mitochondrial fragmentation. OMA1-deficient mice are viable but suffer from diet-induced obesity and show impaired thermogenesis, which suggests important functions of OMA1 and stress-induced OPA1 processing for metabolic homeostasis ([@bib33]). Depletion of YME1L, however, impairs constitutive processing of OPA1 at S2 ([@bib15]; [@bib39]) and causes the fragmentation of the mitochondrial network, perturbs cristae morphogenesis, and renders cells susceptible to apoptosis ([@bib40]).

To further define the role of YME1L and OMA1 in OPA1 processing and mitochondrial morphology, we generated cell lines lacking either or both proteases and examined the dynamic behavior of mitochondria. Our experiments demonstrate that OPA1 processing is dispensable for mitochondrial fusion and suggest a stimulatory role of S-OPA1 for mitochondrial fission.

Results and discussion
======================

Long OPA1 forms are sufficient to mediate mitochondrial fusion
--------------------------------------------------------------

We generated mouse embryonic fibroblasts (MEFs) that were deficient for the proteases required for OPA1 processing, *Yme1l^−/−^*, *Oma1^−/−^*, and *Yme1l^−/−^Oma1^−/−^* (double knockout \[DKO\]). These cells propagated normally, which indicates that YME1L and OMA1 are dispensable for cell growth. As expected, *Yme1l^−/−^* cells showed fragmented mitochondria, whereas deletion of *Oma1* did not grossly impair the mitochondrial network ([Fig. 1, A and B](#fig1){ref-type="fig"}). Surprisingly, we observed tubular mitochondria in DKO cells lacking both YME1L and OMA1 ([Fig. 1, A and B](#fig1){ref-type="fig"}). Mitochondria formed short tubules in DKO cells, which were different from the fragmented mitochondria of *Yme1l^−/−^* cells ([Fig. 1, A and B](#fig1){ref-type="fig"}). Mitochondrial tubulation in DKO cells depended on OPA1, as siRNA-mediated down-regulation of OPA1 led to mitochondrial fragmentation ([Fig. S1, A and B](http://www.jcb.org/cgi/content/full/jcb.201308006/DC1){#supp1}). Although total OPA1 levels were moderately increased, steady-state levels of proteins involved in mitochondrial morphogenesis were unchanged in cells lacking both proteases (Fig. S1 C).

![**Loss of OMA1 restores tubular mitochondria in *Yme1l*^−/−^ cells.** (A) Representative images of mitochondrial morphology in MEFs. The asterisks denote the area of magnification enlarged on the right. Bars: (left) 15 µm; (right) 5 µm. (B) Quantification of three independent experiments (error bars indicate mean ± SD), *n* ≥ 100. (C) Accumulation of OPA1 forms in MEFs lacking YME1L, OMA1, or both. Cells lysates were analyzed by SDS-PAGE analysis and immunoblotting using the indicated antibodies. a--e, OPA1 forms. (D) Schematic representation of mature L-OPA1 forms derived from splice variants 1 and 7 and S-OPA1 forms produced by cleavage at proteolytic sites S1 or S2 by OMA1 or YME1L, respectively.](JCB_201308006_Fig1){#fig1}

We monitored OPA1 processing in cells lacking YME1L and OMA1 by immunoblotting. At least five distinct forms (a--e) of OPA1 generated from splice variants 1 and 7 accumulate in mitochondria in MEFs ([Fig. 1, C and D](#fig1){ref-type="fig"}). OMA1 cleaves L-OPA1 at S1 and generates S-OPA1 forms c and e ([@bib11]; [@bib17]; [@bib33]), which were absent in *Oma1*^−/−^ cells ([Fig. 1 C](#fig1){ref-type="fig"}). However, the S-OPA1 form d produced by S2 cleavage of L-OPA1 was not present in *Yme1l^−/−^* cells ([Fig. 1 C](#fig1){ref-type="fig"}), as previously observed in YME1L-depleted cells ([@bib39]; [@bib40]). We observed increased amounts of S-OPA1 forms c and e in *Yme1l^−/−^* cells, which indicates accelerated OPA1 processing at S1 by OMA1 ([Fig. 1 C](#fig1){ref-type="fig"}). Notably, DKO cells contained L-OPA1 forms but were completely devoid of S-OPA1 ([Fig. 1 C](#fig1){ref-type="fig"}). We therefore conclude that YME1L and OMA1 are the only proteases that process L-OPA1 and generate S-OPA1 forms under these conditions.

The presence of tubular mitochondria in DKO cells containing only L-OPA1 suggests that mitochondrial membranes can fuse. To directly assess mitochondrial fusion, we transiently expressed a photoactivatable GFP variant targeted to the mitochondrial matrix (matrix-PA-GFP) in wild type (WT) and DKO cells. Upon photoactivation of a small fraction of the mitochondrial network, we examined fusion of mitochondria by tracking the redistribution of GFP fluorescence over time ([Fig. 2 A](#fig2){ref-type="fig"}). We observed efficient mitochondrial fusion in DKO but not in *Opa1*^−/−^ cells ([Fig. 2, A and B](#fig2){ref-type="fig"}; and [Fig. S2 A](http://www.jcb.org/cgi/content/full/jcb.201308006/DC1){#supp2}). Mitochondrial fusion was also observed in DKO cells grown under respiring conditions (Fig. S2 B). We further substantiated the fusion competence of DKO cells by monitoring the fusion of individual mitochondria after photoactivation ([Fig. 2 C](#fig2){ref-type="fig"}). Moreover, assessment of mitochondrial fusion upon expression of PA-GFP targeted to the IM revealed that matrix as well as IM contents are efficiently exchanged in DKO cells (Fig. S2 C), which demonstrates that L-OPA1 is sufficient to mediate complete fusion of mitochondria.

![**OPA1 processing is dispensable for mitochondrial fusion.** (A and B) Photoactivatable GFP (matrix-PA-GFP) and mito-mCherry both targeted to the mitochondrial matrix were expressed in WT, *Yme1l*^−/−^*Oma1*^−/−^, and *Opa1*^−/−^ MEFs (A). Fusion was monitored by the time-dependent dilution and redistribution of PA-GFP fluorescence (top, 1 min; bottom, 60 min). Bars, 15 µm. (B) Quantification of mitochondrial fusion. Results are represented in the form of a box plot: boxes represent data between the 25th and 75th percentiles, lines extend between the 10th and 90th percentiles, the horizontal line indicates the median, and the circle indicates the mean value (*n* ≥ 14; *Yme1l*^−/−^*Oma1*^−/−^ vs. WT, P = 0.8; *Yme1l*^−/−^*Oma1*^−/−^ vs. *Opa1*^−/−^, P = 1.6 × 10^−12^; WT vs. *Opa1*^−/−^, P = 4.6 × 10^−8^; \*\*\*, P ≤ 0.001). (C) Visualization of individual fusion events in *Yme1l*^−/−^*Oma1*^−/−^ MEFs using matrix-PA-GFP and mito-mCherry. The arrowheads indicate mitochondria that have acquired photoactivated GFP due to fusion with photoactivated mitochondria. Bar, 5 µm. (D) Mitochondrial morphology in *Opa1*^−/−^ MEFs expressing cleavable or noncleavable OPA1 forms. Flag-tagged variants of human OPA1 isoform 1 (S1-Flag), isoform 1 lacking the S1 site (ΔS1-Flag), or ΔS1-Flag^K301A^ were transiently expressed in *Opa1*^−/−^ cells. The mitochondrial network was visualized using a TOM20-specific antibody. Bar, 15 µm. (E) Quantification of three independent experiments (error bars indicate mean ± SD), *n* ≥ 100.](JCB_201308006_Fig2){#fig2}

We expressed the human OPA1 isoform 1 and a variant thereof lacking S1 in *Opa1*^−/−^ cells and assessed mitochondrial morphology. The loss of OPA1 results in the fragmentation of the mitochondrial network, which was at least partially restored upon expression of human isoform 1 of OPA1 ([Fig. 2, D and E](#fig2){ref-type="fig"}). Unlike previous observations ([@bib39]), deletion of S1 did not significantly affect the ability of OPA1 to maintain tubular mitochondria, which indicates that OPA1 processing is dispensable ([Fig. 2, D and E](#fig2){ref-type="fig"}). However, tubulation was not observed upon expression of noncleavable OPA1 harboring a GTPase mutation in *Opa1*^−/−^ cells ([Fig. 2, D and E](#fig2){ref-type="fig"}).

These experiments indicate that L-OPA1 is sufficient to mediate mitochondrial fusion. L-OPA1 appears to be matured completely by the matrix-localized mitochondrial processing peptidase in DKO cells. Alkaline extraction of mitochondrial membranes at different pH indicated that membrane insertion of L-OPA1 was not significantly altered in DKO cells when compared with WT cells (Fig. S1 D). However, these experiments do not exclude the possibility that a small fraction of L-OPA1 fails to insert properly in the IM of DKO cells, thereby mimicking the function of S-OPA1. Nevertheless, our experiments in DKO cells indicate unambiguously that mitochondrial fusion does not depend on OPA1 processing. This is in agreement with previous OPA1 knockdown experiments in HeLa cells ([@bib18]) and the observation that noncleavable L-OPA1 is sufficient to promote stress-induced mitochondrial hyperfusion (SIMH) in *Opa1*^−/−^ cells ([@bib42]). Consistently, we observed SIMH in DKO cells (Fig. S2, D and E).

Long OPA1 forms preserve cristae morphology and apoptotic resistance
--------------------------------------------------------------------

We examined the ultrastructure of mitochondria in DKO cells by transmission electron microscopy, as cristae morphology is known to depend on OPA1 (or Mgm1 in yeast; [@bib29]; [@bib24]). We observed normally shaped cristae in *Oma1*^−/−^ cells but severely disorganized and swollen cristae in *Yme1l*^−/−^ cells ([Fig. 3 A](#fig3){ref-type="fig"}), as previously observed in YME1L-depleted HEK293T cells ([@bib40]). Strikingly, the mitochondrial ultrastructure was completely restored in DKO cells ([Fig. 3 A](#fig3){ref-type="fig"}), demonstrating that L-OPA1 is sufficient to maintain the tubular, sheet-like structure of mitochondrial cristae.

![**Loss of OMA1 restores cristae morphology and apoptotic resistance of *Yme1l*^−/−^ cells.** (A) WT, *Oma1*^−/−^, *Yme1l*^−/−^, and *Yme1l*^−/−^*Oma1*^−/−^ MEFs were analyzed by transmission electron microscopy. Bar, 1 µm. (B--D) WT and protease-deficient MEFs were exposed to H~2~O~2~ to induce apoptosis. (B) Immunoblot analysis of apoptotic marker proteins (cleaved PARP, cPARP; caspase 3, CASP). (C and D) Flow cytometry analysis of viable cells (Q3: 7-AAD−;APC−) and late apoptotic cells (Q2: 7-AAD+; APC+). \*, P ≤ 0.05; \*\*\*, P ≤ 0.001. Error bars indicate mean ± SD.](JCB_201308006_Fig3){#fig3}

Apoptosis is associated with the reshaping of mitochondrial cristae controlled by OPA1 ([@bib29]; [@bib13]; [@bib25]; [@bib48]). Overexpression of OPA1 confers apoptotic resistance ([@bib13]), whereas loss of OPA1 ([@bib6]) or the selective loss of L-OPA1 alone ([@bib25]) increases the apoptotic sensitivity of cells. We therefore assessed the susceptibility of cells lacking YME1L, OMA1, or both to H~2~O~2~-induced apoptosis, monitoring the accumulation of apoptotic markers ([Fig. 3, B--D](#fig3){ref-type="fig"}). Cells depleted of YME1L were reported to be more susceptible to apoptosis, whereas loss of OMA1 protects cells against apoptosis ([@bib33]; [@bib40]). Consistently, cleaved poly ADP-ribose polymerase (cPARP) and activated caspase 3 accumulated in H~2~O~2~-treated *Yme1l*^−/−^ cells but not in *Oma1^−/−^* cells, whose apoptotic sensitivity was decreased when compared with WT cells ([Fig. 3, B--D](#fig3){ref-type="fig"}). Deletion of *Oma1* protected *Yme1l*^−/−^ cells against apoptosis ([Fig. 3, B--D](#fig3){ref-type="fig"}). We therefore conclude that L-OPA1 confers apoptotic resistance to cells.

Short OPA1 forms trigger mitochondrial fragmentation in Yme1l^−/−^ cells and colocalize with the fission machinery
------------------------------------------------------------------------------------------------------------------

Our findings raise the question of why fragmented mitochondria accumulate in *Yme1l*^−/−^ cells that contain similar levels of L-OPA1 as WT cells ([Fig. 1 C](#fig1){ref-type="fig"}). We noted a striking correlation of the accumulation of S-OPA1 with mitochondrial fragmentation and apoptosis. Although a tubular network is preserved in *Oma1*^−/−^ cells lacking S-OPA1 forms c and e, mitochondrial fragmentation in *Yme1l*^−/−^ cells is associated with an accumulation of these S-OPA1 forms generated by OMA1 ([Figs. 1 C](#fig1){ref-type="fig"} and [3 B](#fig3){ref-type="fig"}). This effect is even more pronounced upon H~2~O~2~-induced apoptosis, which destabilizes L-OPA1 and leads to the formation of S-OPA1 by OMA1 in WT and *Yme1l*^−/−^ cells ([Fig. 3 B](#fig3){ref-type="fig"}). We therefore reasoned that the accumulation of S-OPA1 may trigger mitochondrial fragmentation in the absence of YME1L, either by inhibiting fusion or by stimulating fission.

Mitochondrial fusion proceeded normally in *Yme1l*^−/−^ cells ([Fig. 4, A and B](#fig4){ref-type="fig"}), which is consistent with recent YME1L knockdown experiments ([@bib35]). To examine if S-OPA1 can induce mitochondrial fission, we ectopically expressed a hybrid protein of S-OPA1 and the amino-terminal region of apoptosis-inducing factor (AIF) containing the mitochondrial targeting signal ([@bib18]). A significant proportion of WT and DKO cells expressing S-OPA1 showed mitochondrial fragmentation ([Fig. 4, C and D](#fig4){ref-type="fig"}; and [Fig. S3 A](http://www.jcb.org/cgi/content/full/jcb.201308006/DC1){#supp3}). S-OPA1 forms c and d fragment mitochondria, which indicates a similar activity of different S-OPA1 forms (Fig. S3 A). Moreover, mitochondrial fragmentation was observed upon expression of S-OPA1 in HEK293T cells (Fig. S3, B--E). Thus, although loss of OMA1, and concomitantly S-OPA1 forms c and e, restored a tubular network in the absence of YME1L, reintroduction of S-OPA1 in DKO cells triggered mitochondrial fragmentation. Notably, this is not a canonical stress response, as fragmented mitochondria in DKO cells expressing S-OPA1 can fuse ([Fig. 4, E and F](#fig4){ref-type="fig"}) and retain normal membrane potential (Fig. S3, F and G). These experiments therefore strongly suggest that mitochondrial fragmentation in *Yme1l*^−/−^ cells is caused by an unbalanced processing of OPA1 and indicate that S-OPA1 is functionally linked to mitochondrial fission.

![**The function of short OPA1 forms is linked to mitochondrial fission.** (A) Mitochondria fuse in *Yme1*^−/−^ cells. Mitochondrial fusion was analyzed as in [Fig. 2](#fig2){ref-type="fig"} using matrix-PA-GFP. (B) Quantification of mitochondrial fusion in *Yme1l*^−/−^ cells after 60 min. Results are represented in the form of a box plot (see [Fig. 2](#fig2){ref-type="fig"}). WT versus *Yme1l*^−/−^ cells, P = 0.14. (C) Expression of S-OPA1 forms in *Yme1l*^−/−^*Oma1*^−/−^ cells induces mitochondrial fragmentation. Mitochondrial morphology was assessed in *Yme1l*^−/−^*Oma1*^−/−^ MEFs expressing Flag-tagged variants of rat S-OPA1-Flag or S-OPA1^K301A^-Flag (bottom) harboring a mutation in the GTPase domain of OPA1. (D) Quantification of three independent experiments (error bars indicate mean ± SD). *n* ≥ 100; \*\*, P ≥ 0.01. (E) Mitochondrial fusion occurs in fragmented mitochondria of WT and *Yme1l*^−/−^*Oma1*^−/−^ cells expressing S-OPA1-Flag. (F) Quantification of mitochondrial fusion after 60 min. Results are shown in the form of a box plot (see [Fig. 2](#fig2){ref-type="fig"}). Shown are WT/*Yme1l*^−/−^*Oma1*^−/−^ cells versus WT/*Yme1l*^−/−^*Oma1*^−/−^ cells expressing rat S-OPA1. Bars, 15 µm.](JCB_201308006_Fig4){#fig4}

We expressed mitochondrially targeted S-OPA1^K301A^, harboring a mutation in the GTPase domain of OPA1, in DKO cells. Tubular mitochondria were preserved in a significantly increased proportion of cells when compared with DKO cells expressing S-OPA1 ([Fig. 4, C and D](#fig4){ref-type="fig"}; and Fig. S3, B and C). Mitochondrial fragmentation upon overexpression of S-OPA1^K301A^ may reflect intermolecular complementation of the GTPase activity by endogenous L-OPA1 within an OPA1 oligomer, as has been described previously for yeast Mgm1 ([@bib9]; [@bib51]). Interestingly, we observed that S-OPA1^K301A^ assembled into punctate structures in mitochondria, as opposed to S-OPA1 or noncleavable L-OPA1^K301A^, which were uniformly dispersed within the organelle ([Figs. 4 C](#fig4){ref-type="fig"} and S3 A). A similar punctate distribution has been observed for the mitochondrial fission machinery, which is recruited to mitochondrial fission sites marked by the ER ([@bib14]; [@bib27]). We therefore visualized ER--mitochondria contact sites by fluorescence microscopy of DKO cells and assessed the degree of colocalization of S-OPA1^K301A^ punctae with these sites. Strikingly, ∼50% of these punctae localized at ER--mitochondria contact sites ([Fig. 5 A](#fig5){ref-type="fig"}), where fission of mitochondrial membranes occurs. A punctate distribution at mitochondrial division sites has also been observed for DRP1 ([@bib37]; [@bib38]) and the DRP1 recruitment factor MID49 ([@bib32]; [@bib50]). Fluorescence microscopy of DKO cells expressing S-OPA1^K301A^ revealed colocalization of ∼15% or ∼30% of the S-OPA1^K301A^ containing punctae with DRP1 or MID49 spots, respectively ([Fig. 5, A and B](#fig5){ref-type="fig"}). Moreover, S-OPA1^K301A^ punctae are conspicuously present at sites of mitochondrial constriction ([Fig. 5 C](#fig5){ref-type="fig"}).

![**GTPase-inactive short OPA1 forms colocalize with sites of mitochondrial division.** (A) S-OPA1^K301A^-Flag expressed in *Yme1l*^−/−^*Oma1*^−/−^ cells assembles into punctae partially colocalizing with ER--mitochondria contact sites (i; a total of 90 spots in five different cells), endogenous DRP1 (ii; a total of 230 spots in five different cells), and endogenous MID49 (iii; a total of 186 spots in six different cells). Bars, 2 µm. (B) Line scan of ii and iii along the lines indicated in A. (C) S-OPA1^K301A^-Flag punctae coalesce at sites of mitochondria constriction. Mitochondria are visualized using mito-mCherry, the ER using GRP78-specific antibodies. Bar, 2 µm.](JCB_201308006_Fig5){#fig5}

Collectively, several lines of evidence support a stimulatory role of S-OPA1 for mitochondrial fission: First, we observed a striking correlation between the accumulation of S-OPA1 and mitochondrial fragmentation in cells lacking YME1L, although fusion of mitochondrial membranes proceeds normally in these cells. Second, ectopic expression of S-OPA1 in DKO cells induces fragmentation of the mitochondrial network, which appears to occur in a GTPase-dependent manner and can be mediated by different S-OPA1 forms. Third, S-OPA1^K301A^ assembles into punctate structures that partially colocalize with ER--mitochondria contact sites, mitochondrial constriction sites, and foci containing DRP1 or MID49. How S-OPA1 affects mitochondrial fission remains to be elucidated. Mitochondrial division occurs in *Opa1*^−/−^ cells and thus does not depend on S-OPA1. However, S-OPA1 may stimulate membrane fission and contribute to the coordination of mitochondrial fusion and fission. Indeed, an increased probability for membrane fission has been observed after a fusion event in various cell types ([@bib43]; [@bib46]; [@bib3]). It is conceivable that S-OPA1 interacts with the fission machinery at the OM or is involved in IM fission. A stimulatory role of S-OPA1 in mitochondrial fission may be crucial under stress conditions or upon induction of apoptosis and/or mitophagy and is therefore likely to be of particular importance for mitochondrial quality control ([@bib49]). In agreement with an active role of S-OPA1 for stress-induced mitochondrial fission, OMA1 is activated under stress, resulting in the increased formation of S-OPA1 forms c and/or e (e.g., in apoptotic cells; [Fig. 3 B](#fig3){ref-type="fig"}). Inhibition of stress-induced OPA1 processing in cells lacking OMA1 is thus likely to affect both mitochondrial fusion and fission: while L-OPA1 is stabilized and fusion preserved, the formation of S-OPA1 forms c and e is prevented, resulting in the maintenance of a tubular mitochondrial network and protection against apoptosis. Loss of YME1L, however, impairs constitutive OPA1 processing at S2 but leads to the OMA1-dependent accumulation of S-OPA1 forms c and e and mitochondrial fragmentation. Our analyses of YME1L- and OMA1-deficient cells thus revealed an unexpected role of OPA1 processing in mitochondrial fusion--fission dynamics, which determine the shape, size, and distribution of these organelles within a cell and thus are paramount to cell physiology.

Materials and methods
=====================

Generation and culture of cell lines
------------------------------------

*Yme1l*^loxP/loxP^ and *Oma1*^loxP/loxP^ conditional mice were generated by conventional ESC targeting using pRapidFlirt constructs designed to insert intronic *LoxP* sites flanking exon 3 of either *Yme1l* or *Oma1*. Germline chimeras were generated on a C57Bl6/N background and subsequently intercrossed to generate *Yme1l*^loxP/loxP^*Oma1*^loxP/loxP^ animals. Primary fibroblasts were isolated from *Yme1l*^loxP/loxP^, *Oma1*^loxP/loxP^, and Yme1l^loxP/loxP^*Oma1*^loxP/loxP^ embryonic day 13.5 embryos and immortalized using a plasmid encoding SV40 large T antigen. Immortalized fibroblasts were transduced with recombinant His-TAT-NLS-Cre (HTNC) fusion protein (4 µM), incubated for 20 h, washed with PBS, and supplemented with growth medium. Individual clones were sorted by flow cytometry into 96-well plates (FACS Aria III; BD) using the FASC DIVA software (BD), expanded, and subsequently genotyped for deletion of *Yme1l* and/or *Oma1* by PCR and immunoblotting. MEFs were grown in DMEM + GlutaMAX (Life Technologies) supplemented with sodium pyruvate (Gibco), nonessential amino acids (Gibco), and 10% fetal calf serum (Life Technologies). Cells were cultured at 37°C in a humidified incubator with 5% CO~2~. Respiring media consisted of DMEM without glucose supplemented with 10% FBS, nonessential amino acids, and galactose (10 mM). *Opa1*^−/−^ cells were grown in glucose-containing media supplemented with 50 µg/ml uridine. S-OPA1 (1--97 amino acids of rat AIF fused to 230--997 amino acids of rat OPA1) and the mutant variant S-OPA1^K301A^ thereof were stably expressed in Flp-In T-Rex HEK293T cells (Invitrogen) under the control of a tetracycline-regulatable promoter according to the manufacturer's instructions.

Confocal fluorescence microscopy
--------------------------------

To monitor mitochondrial morphology by immunofluorescence microscopy, cells were stained with antibodies directed against cytochrome *c* (anti--mouse 1:500; BD) or TOM20 (anti--rabbit 1:500; Santa Cruz Biotechnology, Inc.) or directly visualized with mito-mCherry. The ER was visualized with antibodies directed against GRP78 (anti--mouse 1:200; Abcam), DRP1 foci with DRP1-specific antibodies (anti--mouse 1:200; BD), MID49 foci with MID49-specific antibody (anti--rabbit 1:50; Proteintech), and transiently expressed OPA1 variants using antibodies directed against the Flag epitope (anti--mouse 1:500; Sigma-Aldrich). Cells were fixed with paraformaldehyde (4% \[wt/vol\] in PBS) for 15 min and permeabilized using 0.15% (vol/vol) Triton X-100. 3% (wt/vol) bovine serum albumin in PBS was used for blocking and to dilute primary and secondary antibodies. Fluorescently coupled secondary antibodies Alexa Fluor 488 (goat anti--mouse and goat anti--rabbit), Alexa Fluor 568 (goat anti--mouse and goat anti--rabbit), and Alexa Fluor 633 (goat anti--mouse) were used at 1:1,000 dilution (Invitrogen). Images were acquired using an UltraVIEW VoX spinning disc (CSU-X1; Yokogawa Corporation of America) confocal microscope (PerkinElmer) on a microscope (Ti; Nikon) equipped with a 60× (Apochromat total internal reflection fluorescence 60× oil, NA 1.49) objective lens and camera (EMCCD C9100-50; CamLink). Live cells were imaged in DMEM medium at 37°C with 5% CO~2~. Standard image processing was performed using Volocity (PerkinElmer) and ImageJ ([@bib36]). No image manipulation was performed, except a background subtraction in [Fig. 1](#fig1){ref-type="fig"} (ImageJ, rolling ball with 10 pixel radius). Images in [Fig. 5](#fig5){ref-type="fig"} were deconvolved using Huygens Professional with the "Classical Maximum Likelihood Estimation (CMLE) algorithm" and measured point spread functions of 488-, 546-, and 634-nm channels (Scientific Volume Imaging) before manual analysis for colocalization. For colocalization analyses, S-OPA1 punctae near the periphery of the cell were scored for their 3D coincidence with DRP1, MID49, or ER--mitochondria contact sites using Imaris (Bitplane). 3D visualization in [Fig. 5 C](#fig5){ref-type="fig"} was performed in Volocity (PerkinElmer) using "3D opacity view."

Assessing mitochondrial fusion
------------------------------

5 × 10^4^ cells were transfected with 1 µg matrix-PA-GFP and 0.5 µg mito-mCherry, and imaged after 24 h. Approximately 23 ± 12% of mitochondria were photoactivated using 5% power of a 405-nm laser for one cycle (30 iterations). Z stack images of PA-GFP and mito-mCherry using a step size of 0.3 µm were acquired using 488-nm and 568-nm lasers immediately after photoactivation (1 min delay) and after 20, 40, or 60 min. We thank O. Shirihai (Boston University, Boston, MA) for the plasmid encoding IM-PA-GFP and A. Kumar Kondadi (University of Cologne, Cologne, Germany) for the plasmid encoding mito-mCherry.

Mitochondrial fusion was quantified using a similar approach to one described previously ([@bib52]). The relative amounts of mitochondria containing PA-GFP were compared directly after activation (1 min) and after the indicated time points. The total volume of mitochondria was obtained by thresholding image stacks of mito-mCherry and the volume of mitochondria containing PA-GFP by thresholding the image stacks of PA-GFP. Alterations in the percentage of mitochondria containing PA-GFP were calculated for each time point to determine mitochondrial fusion. Thresholding and image analysis was performed using Volocity (PerkinElmer). Data were represented with boxplots. Boxes represent data between the 25th and 75th percentiles, lines extend between the 10th and 90th percentiles, the horizontal line indicates the median value, and the circle the mean value. Changes in fusion were evaluated by a Student's *t* test.

Transmission electron microscopy
--------------------------------

MEFs were prepared for transmission electron microscopy analysis as previously described ([@bib45]). MEFs were fixed for 1 h in prewarmed 2% (vol/vol) glutaraldehyde, 2.5% (wt/vol) sucrose, 3 mM CaCl~2~, and 100 mM Hepes-KOH, pH 7.4. After washes, MEFs were postfixed using reduced OsO~4~ (1% \[wt/vol\] OsO~4~, 10 mg/ml potassium ferrocyanide, 1.25% \[wt/vol\] sucrose, and 100 mM sodium cacodylate, pH 7.4) for 1 h on ice. After washes in water, cells were incubated in 2% (wt/vol) uranyl acetate for 30 min. After dehydration using 50, 70, 90, and 100% ethanol, samples were embedded in epon resin. Samples were observed under a transmission electron microscope (EM902; Carl Zeiss) at an acceleration voltage of 80 kV, and micrographs were generated at 20,000×.

Analysis of H~2~O~2~-induced apoptosis
--------------------------------------

To induce apoptosis, cells were incubated in the presence of 1 mM H~2~O~2~ for 7 h. Double staining with annexin V (AV) and 7-AAD, as described previously, assessed apoptotic cell death ([@bib34]). Cells were analyzed by flow cytometry (FACS Aria III) using the FASC DIVA software (BD). The accumulation of apoptotic marker proteins, cPARP, and activated caspase 3 (CASP3) was examined in cell lysates by immunoblotting.

Online supplemental material
----------------------------

Fig. S1 shows that the formation of tubular mitochondria in *Yme1l*^−/−^*Oma1*^−/−^ cells depends on OPA1. Fig. S2 shows mitochondrial fusion in *Yme1l*^−/−^*Oma1*^−/−^ cells. Fig. S3 shows that ectopic S-OPA1 expression induces mitochondrial fragmentation but does not cause general mitochondrial dysfunction. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.201308006/DC1>.
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